Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Taunton

Orthopaedic Surgery Rochester, MN Medical Doctor

NPI 1992784854 CMS profile 362412

200 1St St Sw, Rochester, MN 55905

Open in the dashboard

General payments

$3,530,758

623 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$15,295 paid to institutions, not to them · program year 2019

Through program year 2025, Michael Taunton of Rochester, MN is reported in the CMS Open Payments database as having received $3,530,758 across 623 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $15,295 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,596,843 64
2024 General $158,500 116
2023 General $147,508 98
2022 General $177,002 140
2021 General $507,067 112
2020 General $487,648 40
2019 General $456,191 53

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Taunton
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Michael Taunton were reported at $1,596,843. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Michael Taunton Orthopaedic Surgery median Middle half National median
2019 $456,191 $644 $140–$2,844 $163
2020 $487,648 $312 $75–$1,860 $114
2021 $507,067 $520 $117–$2,495 $132
2022 $177,002 $598 $128–$2,731 $149
2023 $147,508 $461 $128–$2,264 $160
2024 $158,500 $497 $134–$2,475 $164
2025 $1,596,843 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Encore Medical, LP $3,472,652 592 payments
  2. Djo, LLC $45,629 14 payments
  3. Insight Medical Systems, Inc. $11,517 12 payments
  4. Medical Device Business Services, Inc. $675 1 payment
  5. DePuy Synthes Sales Inc. $106 1 payment
  6. Onkos Surgical, Inc. $105 1 payment
  7. Orthalign Inc $48 1 payment
  8. Globus Medical, Inc. $25 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $2,742,458 52 payments
  2. Consulting Fee $696,325 342 payments
  3. Travel and Lodging $86,675 143 payments
  4. Food and Beverage $5,300 86 payments
Products named General payments · program years 2019–2025
  1. DJO Surgical Empowr Knee System Joint Implants $830,446 50 payments
  2. DJO Surgical Exprt Revision Knee Joint Implants $777,239 22 payments
  3. DJO Surgical Empowr Knee System Joint Implants $457,180 33 payments
  4. DJO Surgical Exprt Revision Knee Joint Implants $440,075 6 payments
  5. DJO Surgical Empowr Acetabular Cup $440,075 6 payments
  6. DJO SURGICAL Joint Implants $224,627 126 payments
  7. DJO SURGICAL Joint Implants $88,014 78 payments
  8. DJO SURGICAL Joint Implants $85,292 64 payments
  9. DJO SURGICAL Joint Implants $84,652 25 payments
  10. DJO Surgical TaperFill Hip System $56,165 6 payments
  11. Other $352,670 201 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 36 billing codes

Paid by Medicare

$211,998

Of which drugs: $215

Medicare patients

338

Average age 73

Services billed

1,993

180 women, 158 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 67%
Ischemic heart disease 23%
Chronic kidney disease 23%
Depression 19%
Cancer 18%
Atrial fibrillation 17%
Osteoporosis 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 12 1,480 $155

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

623 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Minnesota

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record